Human intestinal microbiota and gut mucosal environment (Gut Microbiome/Mucosa)

The human intestinal microbiota and gut mucosal environment constitute a complex, dynamic ecosystem essential for maintaining host homeostasis. The microbiota consists of trillions of bacteria, fungi, viruses, and archaea that reside primarily in the large intestine, performing vital functions such as the fermentation of non-digestible carbohydrates into short-chain fatty acids (SCFAs), vitamin synthesis, and protection against pathogen colonization (NIH, 2023). The gut mucosal environment, including the mucus layer and the underlying epithelial cells, serves as a critical interface for host-microbe interactions and acts as a selective barrier (Nature Reviews Microbiology, 2021). Disruptions to this system, termed dysbiosis, are implicated in the pathogenesis of various diseases, including inflammatory bowel disease (IBD), irritable bowel syndrome (IBS), obesity, and metabolic syndrome (PubMed, 2022). Therapeutic strategies targeting this environment range from broad-spectrum antibiotics and targeted antimicrobials to probiotics, prebiotics, and fecal microbiota transplantation (FMT), all aimed at restoring a healthy microbial balance and reinforcing the mucosal barrier (StatPearls, 2023). This entry is classified as incorrect as a therapeutic target because it represents a broad biological system and environment rather than a specific molecular entity like a receptor or enzyme.

Other names

Gut floraIntestinal microbiomeGut-associated lymphoid tissue (GALT)Intestinal barrierGastrointestinal microbiota

Modulation of microbial composition, restoration of eubiosis, production of short-chain fatty acids (SCFAs), and enhancement of mucosal barrier function.